Sectional Editor: Histopathology
Department of Histopathology
University College Hospitals London
I am a professor of Haematopathology at UCL and a consultant Haematopathologist at UCLH. I head a research team at the UCL Cancer Institute, and I developed collaborations across different research groups within UCL and across UK, Europe and America.
My research career began in 1993 in Berlin under Prof. H. Stein, one of the stalwarts of Haematopathology, as a clinical research fellow focussed on the pathogenesis of Hodgkin Lymphoma (HL). Using cutting edge technology at the time – single cell microdissection and sequencing – we provided definitive evidence for identifying the lineage of neoplastic cells in Hodgkin Lymphoma. This work was published in the New England Journal of Medicine in 1997 and I was first author.
In February 2000, I moved to the University of Oxford to work under Prof D. Y. Mason on the development of monoclonal antibodies against intracellular proteins to investigate normal lymphocyte biology and lymphoma diagnosis. This led to the discovery of unique biomarkers such as PD-1, ICOS, and CD2AP that helped in reclassifying specific lymphoma entities. They are now in routine diagnostic use and have been included in the WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2017- the gold standard amongst published diagnostic guidelines.
Since January 2010 my work at UCLH has been funded jointly by the NHS Trust and UCL/UCLH BRC with protected research sessions that enable a 50:50 split between academic/research and diagnostic work. I have continued my research in haemato-oncology and extended it to characterization of lymphocyte anti-tumour cells in collaboration with the ongoing immunotherapy programmes at UCL/UCLH and external groups. In 2015, I co-authored the guidelines on investigation and management of Nodular Lymphocyte Predominant Hodgkin Lymphoma, the first such guideline published by the British Committee for Standards in Haematology (BCSH) on this topic.
Below are detailes of my research streams and some specific examples:
1. Identification of Novel Markers for Lymphoma Diagnostics.
a. Stathmin (STMN1), a novel diagnostic marker for follicular lymphoma subgroups with an “atypical” immunophenotypic and molecular profile. STMN1 is of potential relevance for therapeutic clinical trials.This article published in J of Pathology received the 2013 Roger Cotton Prize;
b. BRAF (V600E), a useful diagnostic and therapeutic target for subsets of transformed chronic lymphocytic leukaemia (Richter’s Syndrome) (Br J Haematol 2015);
c. Granulysin, a diagnostic marker for NK/T cell malignancies (Virchows Archiv 2019);
d. FOXP-1, diagnostically relevant to distinguish paediatric follicular lymphoma from benign follicular hyperplasia (Virchows Archiv 2018);
2. Development of Novel Technologies for the Study of Lymphocyte Biology and Tissue Diagnostics
a. I have pioneered the development of multiplex immunostaining (MIS) to detect up to 7 different antigens in tissue samples. This is of diagnostic value in difficult to define lymphomatous entities and in defining the T-cell antitumour response in cancerous tissues. Recently, I have also modified existing techniques to enable multispectral multiplex immunofluorescence using the VECTRA platform. This allows quantitative assessment of multiple, cell surface and intracellular, antigens to detect potential mechanisms of tumour immune-escape. This technique has been applied to three large clinical studies on Burkitt, Follicular lymphoma and classical Hodgkin lymphoma cases (data in progress).
b. I have established techniques for the identification of specific RNAs cancer biomarkers when the protein is not adequately expressed or antibodies to that protein are not available. This has proved to be useful for the detection of minimal residual disease in acute myeloid leukaemia (data under review) and in breast cancer where the HER2 protein expression may be lost but the RNA is still present.
3. Studies of the anti-tumour T-cell response in cancerous tissues
Capitalising on my knowledge of lymphocyte biology and my technical expertise to identify lymphocyte subsets, I have developed collaborations with the immune-therapy teams in the UCL Cancer Institute, CRICK and Imperial College London, who work on checkpoint inhibition, tumour neo-antigens and CAR T-cell therapies. This has been particularly productive for publications in leading scientific journals such as Science (2016), Lancet (2017), and Annals of Oncology (2018).
Research Interests: Immunology, Oncology, Haematopathology as well as Immunohistochemistry-based techniques and digital pathology
Sectional Editor: Internal Medicine
School of Medicine and Health Sciences
George Washington University
Sabyasachi Sen, MD, FACP, FACE is board-certified in Endocrinology and Internal Medicine. He is also an associate professor The George Washington University School of Medicine & Health Sciences. Dr. Sen attended medical school at Calcutta University in India. Dr. Sen completed his Internal Medicine residency from Tufts University School of Medicine and a fellowship in endocrinology from the National Institutes of Health. He undertook extensive training in Internal Medicine Endocrinology then completed his doctorate in Medicine from Britain and Ireland. Previously, he was an Endocrinology faculty member at Tufts University School of Medicine.
Dr. Sen’s basic research interest involves behavior (survival and differentiation) of human adult stem cells in hyperglycemia. His current research projects include: the effect of exercise and incretins on endothelial dysfunction and endothelial progenitor cells in patients with Prediabetes and early type 2 diabetes; use of apoptosis resistant endothelial progenitor cells to increase collateral vessel formation in diabetes with peripheral vascular disease; and use of genetically engineered mesenchymal stem cells to reduce inflammation and insulin resistance in diabetes. In 2012, he received the American Heart Association’s Scientific Development Grant and Investigator Initiated Study Grant from the Together on Diabetes Project, a scientific grant funding mechanism from Bristol Myers Squibb.
Dr. Sen has won several awards for oral presentations at American Heart Association and The Endocrine Society. He is a member of the Royal College of Physicians, London; the American Heart Association, American Diabetes Association and the Endocrine Society, and is also a Fellow of the American College of Physicians and American College of Endocrinology.
Research Interests: survival and differentiation of human adult stem cells in hyperglycemia, use of stem cells to treat diabetes complications such as NASH, CKD, MI and PVD, and use of adult stem cells to predict cardio-metabolic health in response to exercise, artificial sweeteners, food additives and diabetes medications.
Sectional Editor: Clinical Pathology
Researcher of Clinical Pathology
Department of Advanced Clinical and Surgical Sciences
University of Campania "Luigi Vanvitelli"
(1997) Degree in Medicine and Surgery at the Federico II University of Naples, Italy. Thesis carried out at the Department of Internal Medicine of the Federico II University of Naples and in collaboration with the Institute of Food Sciences-CNR Avellino.
(2003) Specialization in Pathology and Cytopathology at University of Naples Federico II, Department of Pathology.
(2006) PhD in Clinical and Pathological Morphology at University of Naples Federico II, Department of Pathology.
(2014/2016) Teaching of Pathological Anatomy in the integrated Anatom course. Patol. Microbiol. And prop. Clinic at the nursing degree course of the Department of Medical and Translational Sciences, Federico II University of Naples, Italy.
(2018/2019) Teaching of "Autopsy and histopathological correlates" at the School of Specialization in Legal Medicine, Federico II University of Naples; scientific collaboration in the field of diagnostic findings both in the clinical and medico-legal fields.
(from 2004 to 2014) Participation in ECM accredited courses as speaker / teacher for the "Theoretical-practical course. Advanced Course in Pathophysiology, Diagnostics and Therapy of Neuroendocrine Tumors, NET Multidisciplinary Group. Federico II University, Naples.
(from 01.04.2004 to 2019) Assistance and training of medical specialists in the branch of Pathology at the Departmant of Onco-hematology, Diagnostic Imaging and Morphology and Legal Medicine of the Federico II University of Naples, carried out in the context of the professional performance care assignments concerning the following sectors: dermatopathology, uropathology, head and neck pathology as well as immunohistochemistry, morphometry, evaluation of the cellular DNA content (ploidy DNA) by means of image analysis . Number of reports made about 3000 per year.
(2020) Researcher in clinical pathology at the University of Campania Luigi Vanvitelli, Italy.
Author and Co-Author of 52 papers in international journals relating to basic experimental research with particular reference to the field of cardiovascular and oncological pathologies (basic histopathology, immunohistochemistry, morphometry, evaluation of the cellular DNA content (DNA ploidy), analysis of image, ancillary methods), and clinical and forensic autopsy, laboratory medicine and transplants.
Research Interest: Cardiovascular and pulmonary pathology, Clinical pathology and pathology of hearth transplantation, Background in oncological pathology and skin pathology
Sectional Editor: Molecular Pathology
Dept. of Medical, Oral and Biotechnological Sciences
Unit of Immunity and Molecular Pathology
School of Medicine and Health Sciences
University “G. d’Annunzio” Chieti-Pescara
Via dei Vestini, Chieti, Italy
Dr.ssa Reale is author of 160 peer-reviewed pubblication and 3 books chapter in neuroimmunology, inflammatory diseases and cytokines (Orcid n. 0000-0002-4164-8781).
Dr.ssa Reale’s goals are to identify the pathogenic role of inflammatory cytokines and, to follow disease activity and to monitor therapeutic responses.
Her research deals with the inflammatory responses and neurodegeneration, in particular the characterization of functional and immunological activation of peripheral cells in inflammatory disease in humans, the cytokines/chemokines network, non-neuronal cholinergic system and their activation pathways, mechanisms for a7nAChR–based pathways in establishing production of inflammatory cytokines as possible strategies for therapeutical intervention by new drugs in autoimmune diseases and neurodegeneration. Dr.ssa Reale is referee of 35 National and International Journals, and member of 7 International Editorial Boards. She has many years of experience in research laboratory management and leadership. She enjoy teaching General Pathology and Immunology to undergraduate and graduate medicine students at School of Medicine, of “G.d’Annunzio” University.
Research Interests: Inflammation, cytokines, neurodegenerative disease, neuroinflammation, autoimmune diseases, probiotics and inflammation.
Sectional Editor: Molecular Medicine
Department of Molecular Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Dr. Sadashiva Karnik is Professor of Molecular Medicine at Cleveland Clinic, Cleveland, Ohio, USA. Dr. Karnik obtained Ph.D. from Indian Institute of Science, Bengaluru in molecular genetics, post-doctoral training at ETH Zurich, Switzerland and MIT, Cambridge, USA. Dr. Karnik joined Cleveland Clinic in 1990 and has been a world leader in the studies on angiotensin receptors with several seminal publications coming from the Karnik’ Laboratory at Cleveland Clinic, Cleveland, USA. His research involves multidisciplinary approach to study molecular basis of Angiotensin functions through its GPCRs. Dr. Karnik is an established investigator in elucidating general mechanisms of GPCRs. His recent studies are focused on structure-based drug discovery and novel drug development.
Renin-angiotensin system, GPCRs, Signal transduction by GPCRs, Drug development for GPCRs
Sectional Editor: Neurophysiology
Senior Academic Researcher
University of Catania
I was born in Catania (Italy) in 1982. I currently work as a Senior Academic Researcher at the University of Catania (Italy). After graduation with honours in Medicine, I trained at the School of Neurology and got the international PhD at the same University. As visiting Clinical Research Fellow, I further trained at the Department of Neuroscience and Clinical Neurophysiology of the Newcastle University (UK). In 2013 I was selected for a Scientific Fellowship promoted by the European Federation of Neurological Societies (EFNS). From 2013 to October 2018, I worked as a Consultant Neurologist at the “Oasi Research Institute–IRCCS” in Troina (Italy), which is a Collaborating Center of the World Health Organization (WHO). From 2015 to October 2018, I taught Neurology at the University of Enna (Italy). I have authored more than 120 publications in internationally-indexed peer-reviewed Journals and Conferences or Meetings, and I currently serve as Editor and invited Reviewer of several international Journals. More recently, I have obtained the Master of Science (Level I) in Clinical Research and the National Scientific Qualification as Associate Professor (procedure for the Italian University Professor recruiting, based on rigorous criteria of scientific qualification).
Neurophysiology, Neuropathology, Neuroscience
Roy G. Beran
Sectional Editor: Medicine
Professor of Medicine
Department of Medicine
University of New South Wales
Sydney, NSW, Australia
Roy G. Beran is trained as a consultant neurologist and accredited sleep physician, in addition to working within legal medicine, military medicine and aviation medicine. His qualifications include: MBBS, MD, FRACP, FRACGP, Grad. Dip. Tertiary Ed., Grad. Dip. Further Ed., FAFPHM, FACLM, FRCP, FAAN, FACBS, B Leg. S, MHL and FFFLM (Hon). He is registered with AHPRA as a specialist in Neurology, Public Health and Sleep Medicine and is a Designated Medical Examiner for the Civil Aviation Safety Authority. He is a medical assessor for Dispute Resolution for the State Insurance Regulatory Authority and an assessor for the Workers Compensation Commission. He is a Conjoint Professor of Medicine at the University of New South Wales; Professor in the School of Medicine at Griffith University, Queensland; and Professor, Chair, Medical Law, Sechenov Moscow 1st State University, Moscow, Russia. He was the inaugural Visiting Professor at the International Research Institute of Health Law Sciences at the Southern Medical University, Guangzhou, Guangdong Province, China.
He is: a founding Fellow of the Australasian College of Legal Medicine; a Past President of the College, having stepped down in 2011, while remaining on Council, and was awarded the second ever Honorary Life Fellowship of the College. He is the Australian Governor and was the Secretary General and remains a Vice President of the World Association for Medical Law (WAML), having served on the Organising Committee of numerous World Congresses on Medical Law, presided over the World Congress, in Sydney, in 2004, and successfully bid to host the World Congress to be held on the Gold Coast, Queensland, in 2022. He was the first Honorary Fellow of the Faculty of Forensic & Legal Medicine of the Royal College of Physicians (London).
In Neurology, he is: a Fellow of the Royal Australasian College of Physicians; a Fellow of the Royal College of Physicians, Edinburgh; Corresponding Fellow of the American Academy of Neurologists; and a Member of the Australian and New Zealand Association of Neurologists. He is a Member of the Australasian Sleep Association, serving on various committees thereof. He pioneered the conduct of clinical trials and undertaking research within private practice, having been principal author in publications which included leading academic/tertiary referral institutions. He has published in the order of 320 papers, book chapters and letters to the editor, presented in excess of 370 papers at national and international meetings and written or edited 15 books, including ‘Legal and Forensic Medicine’, and is on numerous editorial boards, including being the editor in chief of the international journal, Medicine and Law, for the WAML.
He was an officer in the Royal Australian Navy Reserve (holding the rank of Commander) and was awarded membership of the general division of the Order of Australia, in 2015.
Research Interests: Health law & ethics, Epilepsy, Drug trials, Public health, Legal medicine, Legal medicine education, Neurological conditions & new therapies, Rehabilitation, Sleep disorders, Neurological advances in Asia and developing countries
Sectional Editor: Developmental biology
Regenerative Bioscience Center, Department of Animal and Dairy Science
University of Georgia
Hongxiang was born and grew up in China. She received her M.D. and M.Sc. in Neurophysiology from Zhengzhou University, PhD in neuroscience from Peking University. She has a broad research background in neuroscience, including studies on the roles of neuropeptides in spinal modulation of inflammatory and neuropathic nociception in rodent animal models. Over the past 13 years her interests have switched into the field of developmental biology, focusing on the development and maintenance of the tongue, taste papillae and taste buds. Using transgenic mouse models and embryo/organ/cell culture system, her research program includes
1. Demonstration of neural crest contribution to taste bud cells;
2. Characterization of how neural crest derived mesenchymal cells, via molecular signaling pathways, interact with the overlying epithelium for regulating the development and maintenance of taste papillae and taste buds.
Research Interests: Neural crest cells
Sectional Editor: Dermatopathology
Scientific Institute for Research and Healthcare (IRCCS) Foundation Ca’ Granda – Ospedale
Maggiore Policlinico of Milan
University of Milan
Gianluca Nazzaro, MD (Milan, Italy, 1986) is dermatologist assistant at IRCCS Foundation Ospedale Maggiore Policlinico of Milan, University of Milan.
He obtained his master degree and residency in Dermatology and Venereology at the University of Milan under the guidance of Prof. Emilio Berti, Prof. Stefano Veraldi and Prof. Raffaele Gianotti.
Since 2011, he is lecturer at master course of Medicine and Dermatology.
He is author of 99 peer-reviewed articles published in International Journals (H-index 8).
He won EADV Scholarship, AAD Scholarship and furthermore was awarded by the National Society of Dermatology (SIDEMAST) for the best publication among young researchers in 2015. He is member of Alumni Club of EADV, the group of young researchers of EADV.
He has been speaker during national and international congresses about clinical dermatology.
Research Interests: dermoscopy, dermatopathology, tropical dermatology, ultrasonography, history of medicine
Sectional Editor: Immunology
Assistant Professor of Practice/Immunology and Neurobiology Laboratory Coordinator
Department of Biology
University of Texas at San Antonio
San Antonio, Texas, USA
My name is Michael Hanna. I was an Assistant Professor in the Department of Biology and Environmental Sciences at Texas A&M University-Commerce. Currently I serve as an Assistant Professor of Practice as well as the Immunology and Neurobiology Laboratory Coordinator at the University of Texas at San Antonio. Previously I was an instructor of anatomy and physiology I & II at Blinn College in Bryan, TX.
In 2004 I received my Ph.D. in neuroscience from the University of Rochester. Subsequently I had four years of postdoctoral training at the National Institutes for Neurological Disorders and Stroke at the National Institutes of Health. For the last fourteen years I had been committed to providing quality higher education to undergraduate and graduate students for majors and non-major students. I have taught face to face and online courses covering ten different subject areas Appreciation of my teaching excellence has been recognized with two Texas A&M University System Teaching Excellence Awards in 2010 and 2011.
Research Interests: Immunology, Neurobiology, Neuroscience
Sectional Editor: Physiopathology
Anatomy and Physiopathology Division
Department of Clinical and Experimental Sciences
University of Brescia
Dr. Rita Rezzani is Full Professor of Human Anatomy and Chairman of the Anatomy and Physiopathology Division of the Department of Clinical and Experimental Sciences at University of Brescia (Italy). Her scientific fields of work include the immunosuppressive effects of cyclosporine A, the morphological alterations induced by several pathogenetic processes and also the therapeutic and protective effects of natural antioxidants, in particular of melatonin, in various diseases. She is Director of the Interdipartimental Research Center “Adaptation and Regeneration of Tissues and Organs - ARTO” of University of Brescia (Italy). Furthermore, she is author of more than 220 full-length peer-reviewed international publications and also of books, book chapters and monographs on Systematic Anatomy, Microscopic Anatomy, Topographic Anatomy, Surgical Anatomy, Tissue regeneration and Neuroscience.
Research Interests: Anatomy, Antioxidants, Inflammation, Melatonin, Morphology, Oxidative Stress
Maria Teresa Capucchio
Sectional Editor: Histopathology
Department of Veterinary Sciences
University of Torino
DVM, PhD, Associate Professor of General Pathology at the University of Torino (Italy). He obtained her Bachelor in Veterinary Medicine at Torino University, in 1992, and her PhD in Comparative Pathology from the University of Milano, Italy in 2000, working with Prof. Federico Valenza and Franco Guarda. Her final dissertation was on neuropathology of domestic animals and particularly on Bovine Spongiform Encephalopathy. After completing her PhD, Maria Teresa accepted a position of Researcher (1999-2014) at the Department of Veterinary Sciences, Torino University. During that time, she worked especially on neuropathology of domestic and laboratories animals (tumors, E. cuniculi infection in rabbits, cerebral Theileriosis in cattle, listeriosis) and on pathology due to biological agents. In particular her attention was focused on systemic/local infectious diseases like tuberculosis in large animals. In 2014, she accepted an Associate Professor position at the University of Torino, where she has been since that time. At present she is continuing her works on animal neuropathology, but she moved her main research activity on animal models pathology and on animal production focusing on the evaluation of gut health/systemic morphological alterations following the use of new dietary supplements (natural antioxidants, immunomodulators, milk glycoproteins; antimicrobial peptides, probiotics, insects).
Gut health, Host-pathogens interaction pathology, Neuromuscular pathology, Animal models pathology
Sectional Editor: Parasitology
Department of Human Parasitology
Zhongshan School of Medicine
Sun Yat-sen University
Dr. Lu had been worked in the Dept. of Microbiology/Medicine, Dartmouth Medical School, and the Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, the National Institutes of Health (NIH) as a Visiting Scientist and Research Fellow. So far, Dr. Lu has been awarded 23 scientific grants and has published over 100 peer-reviewed papers.
Immunopathological mechanism of parasitic diseases, Toxoplasma gondii, drug-resistant of Plasmodium parasites, and molecular epidemiology of Plasmodium parasites
Abeer Ahmad Bahnassy
Sectional Editor: Molecular Pathology
Molecular Pathology & Cytogenetics
Dr. Abeer Bahnassy graduated from the Faculty of medicine, Cairo University in 1987 as general practitioner. She worked as a resident, in the National Cancer Institute (NCI), Cairo University (1990-1994), assistant Lecturer of molecular pathology& cytogenetics (1994-1999), lecturer of molecular pathology & cytogenetics (1999-2004), associate professor of Pathology (2004-2009) professor of molecular pathology& cytogenetics and Professor of molecular pathology and Head of molecular pathology & cytogenetics NCI, Cairo University (2009- till now).
Education: Undergraduate studies at Kasr El- Aini School of Medicine from 1977–1982. This was followed by Two year’s prerequisite courses in Cancer Biology, Pathology, Statistics, Molecular Biology, Virology and Immunology, Surgical Oncology and Medical Oncology for fulfillment of her Ph.D. at the NCI, Cairo University .(1989-1991). This was followed by training in the NIH, Bethesda, Maryland, USA (1995-1996) on molecular genetics (DNA, RNA and protein extraction; different PCR techniques; different types of blotting and sequencing). She was also trained and then practiced different molecular cytogenetics technics as a routine work and research including Flourescent in situ hybridization [FISH] and comparative genomic hybridization [CGH]) techniques in this area with more than 6 published manuscripts. Also worked in Fox Chase Cancer Center, Philadelphia, PA, USA (1997-1998) on advanced molecular techniques, cell lines, animal models carcinogenesis, and recently CISH technique.
Dr. Bahnassy and her team also pioneered the establishment of the first Lab in the Middle east at the NCI, Cairo, Egypt for the assessment of Circulating tumor cells (CTCs) and micro satellite instability (MSI). Finally, Dr. Bahnassy also supervised more than 150 master and PhD. theses in the field of molecular pathology of solid (mainly) and hematological malignancies. She also shared and participated in several scientific meetings in Egypt, Europe and USA either as speaker, chair- person or panelist- member.
Research Interests: Molecular pathology
Sectional Editor: Medicine
Nanjing, Jiangsu, China
Sun lingyun, Ph.D., chief physician / professor, doctoral supervisor of Nanjing University, director of the immunology department of the Nanjing Drum Tower Hospital, director of the Institute of Rheumatism and Immunology, Nanjing university. He is a deputy director of the Rheumatology and Immunology Physicians Committee of Chinese Medical Doctor Association and immunology and director of the Society of Rheumatism in Jiangsu Province. In 1998, he took the lead in blood stem cell transplantation in Asia. In 2007, as an international leader in the field of allogeneic bone marrow mesenchymal stem cell transplantation, he treated more than 700 patients.
Research Interest: Rheumatology, Medicine, Immunology, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Osteoarthritis, Systemic Diseases
Sectional Editor: Gastroenterology and Hepatology
Gastroenterology and Hepatology
Shanghai General Hospital, Shanghai Jiaotong University School of Medicine
2009.03~present: Department of Gastroenterology，Shanghai General Hospital, Shanghai Jiaotong University School of Medicine
1999.08～2009.02: Department of Gastroenterology，Shanghai Institute of Digestive Disease，Renji Hospital, Shanghai Jiaotong University School of Medicine
1996.09~ 1999.07: M. D. student at Department of Gastroenterology，Shanghai Institute of Digestive Disease，Renji Hospital，Shanghai Jiaotong University School of Medicine
1990.09~ 1996.08: Working at Department of Gastroenterology，Yangzhou University Medical College
1987.09~ 1990.08: M.S.student in Nanjing Medical University，
1982.09~ 1987.07: B.S.student in Department of Medicine, Yangzhou Medical College
Before 1982: Primary and secondary school
Resaerch Interests: Liver fibrosis; Nonalcoholic liver diseases; cholestasis
Sectional Editor: Medical Biochemistry
Professor and Head of Medical Biochemistry and Molecular Biology Department
Faculty of Medicine
Sally Shalaby was born in Zagazig, Egypt in 1974. She received the M.Sc. and Ph.D degrees in Medical Biochemistry and Molecular Biology from Faculty of Medicine, Zagazig University, Zagazig, Egypt, in 2003 and 2007, respectively. Her Current position is professor and head of Medical Biochemistry Department, Faculty of Medicine, Zagazig University. Her main areas of interest are genetics, immunology and stem cell research. Dr. Sally is a member of the Egyptian Society of Biochemistry & Molecular Biology, the Egyptian Society of Tumor Markers Oncology, and the Arab society of Stem Cells & Molecular Biology. She has 70 publications until now.
Research Interests: Stem cell, Molecular biology and genetics, Clinical chemistry, Immunology
Sectional Editor: Molecular Biology
Department of Molecular Biology
School of Biological Sciences
Madurai Kamaraj University
Tamil Nadu, India
Dr. Subbiah Ramasamy is working as a Sr. Assistant Professor, Department of Molecular Biology/Biochemistry, Madurai Kamaraj University, Tamil Nadu, India. His research interests are Cellular Cardiology, Alcoholic Cardiomyopathy and Environmental Cardiology. He published many articles in peer-review journals.
Research Interests: Cardiac Hypertrophy and Heart Failure, Xenobiotic metabolism and Gut microbiome alterations, Alcoholic Cardiomyopathy, Mitochondrial Dynamics